Peirong Ding, MD, Ph D
Sun Yat-sen University
3
0
0
N/A
0
8
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Jun Huang, MD
Sixth Affiliated Hospital, Sun Yat-sen University
Shared therapeutic areas:
Hyun Kim, M.D.
Washington University School of Medicine
Shared therapeutic areas:
Jean-Philippe Aussel
Sanofi
Shared therapeutic areas:
Carlos Cerdán Santacruz, PhD
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Shared therapeutic areas:
José Mª Taboada
Sanofi
Shared therapeutic areas:
Javier Carrasco, MD, PhD
GHdC
Shared therapeutic areas:
Blas Flor Lorente, PhD
Hospital Politécnico Universitario la Fe
Shared therapeutic areas:
Lei Li, M.D.
Peking Union Medical College Hospital
Shared therapeutic areas:
Worked with same sponsors:
Karen H. Lu, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer
PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients
All 3 trials loaded